Investment Summary

Actis Capital Invests In MédiS Group

On August 2, 2016, private equity firm Actis Capital invested in life science company MédiS Group

Investment Highlights
  • This is Actis Capital’s 3rd transaction in the Life Science sector.
  • This is Actis Capital’s 3rd transaction in Tunisia.

Investment Summary
Date 2016-08-02
Target MédiS Group
Sector Life Science
Investor(s) Actis Capital
Deal Type Growth Capital

Target

MédiS Group

Nabeul, Tunisia
MédiS Group is a prominent branded generic pharmaceuticals business in Tunisia and Algeria. MédiS manufactures a broad portfolio of quality, affordable medicines with strong recognition and trust among doctors and patients. Its products belong to several therapeutic areas, in particular to the chronic pathologies of various specialties such as cardiology, diabetology, neuropsychiatry, cancerology, pain, allergies, gastrology, etc. MédiS also manufactures and markets a wide range of leading-edge medicines such as "biosimilar" products for the treatment of diseases such as deep vein thrombosis, pulmonary embolism, infertility and multiple sclerosis. MédiS Group is based in Nabeul, Tunisia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Actis Capital

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2004
PE ASSETS 24.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Actis Capital is a private equity firm focused on investments in emerging markets. Actis segments its investment activity into three areas. These include private equity, energy, and real estate. Actis' private equity team looks for buyout and growth capital opportunities requiring at least $50 million in financing. Depending on the situation, Actis will consider both controlling and minority investment situations. Sectors of interest include financial services, consumer and retail, business services, and industrial. Actis' energy group seeks to invest in in a variety of energy and utility projects. Actis' real estate team invests equity capital in office, residential, industrial, hotel and retail projects. Actis Capital was established in 2004 and is based in London.

DEAL STATS #
Overall 123 of 144
Sector (Life Science) 3 of 3
Type (Growth Capital) 50 of 54
Country (Tunisia) 3 of 3
Year (2016) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-02 Emerging Markets Payments Holdings

Claremont, South Africa

The Emerging Markets Payments Group was established to deliver world-class electronic payments services to banks, retailers, governments and consumer finance institutions across the Middle East and Africa. Globally, a significant shift is taking place as societies move away from cash-based economies to greater use of electronic payments, a trend that is emphasised in the emerging markets of Africa and the Middle East. This trend offers significant opportunities for all stakeholders, from banks, retailers and card associations through to the end consumer.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-01 Integreon

Fargo, North Dakota, United States

Integreon is a provider of legal, document, business and research support (aka Grail Research) solutions to leading law firms, corporate legal departments, corporate marketing, and strategy groups, financial institutions and professional services firms. Integreon was founded in 1998 and is based in Fargo, North Dakota.

Sell -
Mergr

Product

Company

Legal